… School of Pharmacy and Pharmaceutical Sciences and the university … studied how ticagrelor (Brilinta), the antiplatelet medication, which is used … that a large Clinical Trials Network studying the optimal … could bring that to treatment advantage. We showed that …

… the FDA. For over ten years, ticagrelor (sold as Brilinta in … the trials were not present in US Food and Drug Administration (FDA) … was not involved in the trial, and most investigators, including … . If doctors had known what happened in these trials, they …

… with the U.S. FDA of the De Novo Denial … days of stopping the antiplatelet drug Brilinta. The company determined that a … directly and effectively with senior FDA leadership connecting them with the … , who can provide the FDA with critical insight and expert …

… , the U.K. medical journal BMJ found data integrity … used in the trials were eliminated from FDA datasets, the … -platelet drug.” The BMJ also found that one trial investigator … huge investment in Brilinta after its blockbuster statin treatment Crestor lost …

… , top doctors have warned.  Anti-clotting pill ticagrelor was … whether a treatment is effective—for both trials were inaccurately … US medicine';s regulator, the Food and Drug Administration (FDA) used … .  The twice-daily pill, sold as Brilinta, is given to …

… its FDA approval.  For more than a decade, ticagrelor (Brilinta … the trials were not present in US Food and Drug Administration (FDA) … not involved in the trial, and most investigators, including … bleeding. If doctors had known what happened in these trials, they …

… push a dangerous drug. The company’s COVID-19 vaccine was linked … Brilinta’s trial data. "If doctors had known what happened in these trials … rubber-stamping dangerous drugs under pressure from pharmaceutical lobbyists. Brilinta’s approval followed …

… drug ticagrelor (Brilinta, AstraZeneca), almost 15 years after the medication … US Food and Drug Administration (FDA), and study centers … If doctors had known what happened in these trials, they … conventional wisdom and clinical trial guideline support for… …

… The multibillion dollar heart drug ticagrelor (Brilinta, Brilique) goes generic … results for both clinical trials were inaccurately reported … been recommended in the treatment of patients with acute … AstraZeneca studies that convinced doctors of ticagrelor’s …

… its FDA approval.  For more than a decade, ticagrelor (Brilinta in … the trials were not present in US Food and Drug Administration (FDA) … was not involved in the trial, and most investigators, … . If doctors had known what happened in these trials, they …